Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Clinical trial NCT03642132 · TERMINATED
Trial details
- NCT number
- NCT03642132
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2021-12-22
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.